203 related articles for article (PubMed ID: 26670597)
21. Association of comorbid mood disorders and chronic illness with disability and quality of life in Ontario, Canada.
Gadalla T
Chronic Dis Can; 2008; 28(4):148-54. PubMed ID: 18625088
[TBL] [Abstract][Full Text] [Related]
22. Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.
Johansson P; Mesa R; Scherber R; Abelsson J; Samuelsson J; Birgegård G; Andréasson B
Leuk Lymphoma; 2012 Mar; 53(3):441-4. PubMed ID: 21883029
[TBL] [Abstract][Full Text] [Related]
23. The impact of mood, anxiety, and sleep disorders on fibromyalgia.
Consoli G; Marazziti D; Ciapparelli A; Bazzichi L; Massimetti G; Giacomelli C; Rossi A; Bombardieri S; Dell'Osso L
Compr Psychiatry; 2012 Oct; 53(7):962-7. PubMed ID: 22534032
[TBL] [Abstract][Full Text] [Related]
24. Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score.
Langlais BT; Mazza GL; Kosiorek HE; Palmer J; Mesa R; Dueck AC
J Hematol; 2021 Oct; 10(5):207-211. PubMed ID: 34804309
[TBL] [Abstract][Full Text] [Related]
25. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
26. Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults.
Shillam CR; Dupree Jones K; Miller L
Nurs Res; 2011; 60(5):309-17. PubMed ID: 21873914
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
28. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
[TBL] [Abstract][Full Text] [Related]
29. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of chronic widespread pain in the general population.
Croft P; Rigby AS; Boswell R; Schollum J; Silman A
J Rheumatol; 1993 Apr; 20(4):710-3. PubMed ID: 8496870
[TBL] [Abstract][Full Text] [Related]
31. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
[TBL] [Abstract][Full Text] [Related]
32. Women's health issues with fibromyalgia syndrome.
Shaver JL; Wilbur J; Robinson FP; Wang E; Buntin MS
J Womens Health (Larchmt); 2006 Nov; 15(9):1035-45. PubMed ID: 17125422
[TBL] [Abstract][Full Text] [Related]
33. Coping, self-efficacy and psychiatric history in patients with both chronic widespread pain and chronic fatigue.
Smith WR; Strachan ED; Buchwald D
Gen Hosp Psychiatry; 2009; 31(4):347-52. PubMed ID: 19555795
[TBL] [Abstract][Full Text] [Related]
34. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel RM; Dueck AC; Geyer HL; Kiladjian JJ; Slot S; Zweegman S; te Boekhorst PA; Commandeur S; Schouten HC; Sackmann F; Kerguelen Fuentes A; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Doehner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Mesa RA
J Clin Oncol; 2012 Nov; 30(33):4098-103. PubMed ID: 23071245
[TBL] [Abstract][Full Text] [Related]
35. Fibromyalgia and Obesity: The Association Between Body Mass Index and Disability, Depression, History of Abuse, Medications, and Comorbidities.
Gota CE; Kaouk S; Wilke WS
J Clin Rheumatol; 2015 Sep; 21(6):289-95. PubMed ID: 26308348
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?
Aggarwal VR; McBeth J; Zakrzewska JM; Lunt M; Macfarlane GJ
Int J Epidemiol; 2006 Apr; 35(2):468-76. PubMed ID: 16303810
[TBL] [Abstract][Full Text] [Related]
37. Childhood maltreatment and migraine (part III). Association with comorbid pain conditions.
Tietjen GE; Brandes JL; Peterlin BL; Eloff A; Dafer RM; Stein MR; Drexler E; Martin VT; Hutchinson S; Aurora SK; Recober A; Herial NA; Utley C; White L; Khuder SA
Headache; 2010 Jan; 50(1):42-51. PubMed ID: 19845780
[TBL] [Abstract][Full Text] [Related]
38. Non-motor features in essential tremor.
Chandran V; Pal PK; Reddy JY; Thennarasu K; Yadav R; Shivashankar N
Acta Neurol Scand; 2012 May; 125(5):332-7. PubMed ID: 21777207
[TBL] [Abstract][Full Text] [Related]
39. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
Masruha MR; Lin J; de Souza Vieira DS; Minett TS; Cipolla-Neto J; Zukerman E; Vilanova LC; Peres MF
Headache; 2010 Mar; 50(3):413-9. PubMed ID: 19817880
[TBL] [Abstract][Full Text] [Related]
40. A mind-body technique for symptoms related to fibromyalgia and chronic fatigue.
Toussaint LL; Whipple MO; Abboud LL; Vincent A; Wahner-Roedler DL
Explore (NY); 2012; 8(2):92-8. PubMed ID: 22385563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
